Masatoshi Kanayama

14PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 04, 2026
Upfront surgery for clinical single-station N2 non-small cell lung cancer: real-world outcomes and implications for perioperative strategy.

|Oct 24, 2025
PD-L1 expression as a prognostic factor for postoperative outcomes in pleural mesothelioma.

Masatoshi Kanayama, Takehiko Manabe, Katsuma Yoshimatsu

|Oct 24, 2025
Real-world insights into atezolizumab plus bevacizumab, carboplatin, and paclitaxel for advanced non-squamous non-small cell lung cancer.

Masatoshi Kanayama, Masaru Takenaka, Takehiko Manabe

|Oct 15, 2025
Feasibility and outcomes of curative-intent surgery for clinically node-positive non-small cell lung cancer with interstitial lung disease.

Masatoshi Kanayama, Manabu Yasuda, Toshihiro Osaki

|Jul 29, 2025
Establishing a Highly Accurate Circulating Tumor Cell Image Recognition System for Human Lung Cancer by Pre-Training on Lung Cancer Cell Lines.

Hiroki Matsumiya, Kenji Terabayashi, Yusuke Kishi

|Feb 12, 2025
Immune checkpoint inhibitors in the treatment of pleural mesothelioma: insights from real-world data.

Masatoshi Kanayama, Takehiko Manabe, Katsuma Yoshimatsu

Pageof 3

Frequent Collaborators

2 joint publications

Kazue Yoneda

1 joint publications

Natsumasa Nishizawa

1 joint publications

Masaru Takenaka